ilmscore | Prediction Details
"four of which are in phase two and expecting results within the next two quarters"
By Let's Talk Money! with Joseph Hogue, CFA | January 3, 2025 | Pending
From video
7 Stocks to Buy Now for 100% Returns in 2025 00:11:39 - 00:11:45
Interpreted Prediction
Recursion Pharmaceuticals (RXRX) expects results from four of its Phase 2 drug pipeline trials within the first two quarters of 2025.

Prediction Details

Ticker
RXRX
Initial Price
7.8 USD

Comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.